EMCURE PHARMACEUTICALS
Back to Cashflow Statement
|
EMCURE PHARMACEUTICALS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-814 Cr | ₹-164 Cr | ₹-145 Cr | ₹-152 Cr | ₹-189 Cr |
What is the latest Cash Flow from Financing Activities ratio of EMCURE PHARMACEUTICALS ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-814 Cr |
| Mar2024 | ₹-164 Cr |
| Mar2023 | ₹-145 Cr |
| Mar2022 | ₹-152 Cr |
| Mar2021 | ₹-189 Cr |
How is Cash Flow from Financing Activities of EMCURE PHARMACEUTICALS Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-814 Cr | Negative | |
| Mar2024 | ₹-164 Cr | Negative | |
| Mar2023 | ₹-145 Cr | Negative | |
| Mar2022 | ₹-152 Cr | Negative | |
| Mar2021 | ₹-189 Cr | - | |
Compare Cash Flow from Financing Activities of peers of EMCURE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EMCURE PHARMACEUTICALS | ₹35,361.0 Cr | 4.5% | 2.7% | 38.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹468,842.0 Cr | 1.1% | 4.6% | 14.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹193,860.0 Cr | 0.6% | 8.3% | 8.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹192,687.0 Cr | 6.3% | 12.2% | 45.5% | Stock Analytics | |
| CIPLA | ₹112,593.0 Cr | -1.7% | -2.8% | -4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,364.9 Cr | -3.7% | -10.4% | -6% | Stock Analytics | |
EMCURE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EMCURE PHARMACEUTICALS | 4.5% |
2.7% |
38.7% |
| SENSEX | -1% |
-0.9% |
-7.5% |
You may also like the below Video Courses